Multisite validation of a host response signature for predicting likelihood of bacterial and viral infections in patients with suspected influenza.
Maryam ShojaeiUan-I ChenUros MidicSimone ThairSally TeohAnthony McLeanTimothy E SweeneyMatthew ThompsonOliver LiesenfeldPurvesh KhatriBenjamin TangPublished in: European journal of clinical investigation (2023)
IMX-BVN-1 showed high accuracy for differentiating bacterial and viral infections from noninfectious illness in patients with suspected influenza. Clinical utility of IMX-BVN will be validated following integration into a point of care system.